Enantiospecific total synthesis of the important biogenetic intermediates along the ajmaline pathway, (+)-polyneuridine and (+)-polyneuridine aldehyde, as well as 16-epivellosimine and macusine A.
The first stereospecific synthesis of polyneuridine aldehyde (6), 16-epivellosimine (7), (+)-polyneuridine (8), and (+)-macusine A (9) has been accomplished from commercially available d-(+)-tryptophan methyl ester. d-(+)-Tryptophan has served here both as the chiral auxiliary and the starting material for the synthesis of the common intermediate, (+)-vellosimine (13). This alkaloid was available in enantiospecific fashion in seven reaction vessels in 27% overall yield from d-(+)-trytophan methyl ester (14) via a combination of the asymmetric Pictet-Spengler reaction, Dieckmann cyclization, and a stereocontrolled intramolecular enolate-driven palladium-mediated cross-coupling reaction. A new process for this stereocontrolled intramolecular cross-coupling has been developed via a copper-mediated process. The initial results of this investigation indicated that an enolate-driven palladium-mediated cross-coupling reaction can be accomplished by a copper-mediated process which is less expensive and much easier to work up. An enantiospecific total synthesis of (+)-polyneuridine aldehyde (6), which has been proposed as an important biogenetic intermediate in the biosynthesis of quebrachidine (2), was then accomplished in an overall yield of 14.1% in 13 reaction vessels from d-(+)-tryptophan methyl ester (14). Aldehyde 13 was protected as the N(a)-Boc aldehyde 32 and then converted into the prochiral C(16)-quaternary diol 12 via the practical Tollens' reaction and deprotection. The DDQ-mediated oxidative cyclization and TFA/Et(3)SiH reductive cleavage served as protection/deprotection steps to provide a versatile entry into the three alkaloids polyneuridine aldehyde (6), polyneuridine (8), and macusine A (9) from the quarternary diol 12. The oxidation of the 16-hydroxymethyl group present in the axial position was achieved with the Corey-Kim reagent to provide the desired beta-axial aldehydes, polyneuridine aldehyde (6), and 16-epivellosimine (7) with 100% diastereoselectivity.
Yin
Wenyuan
W
Department of Chemistry & Biochemistry, University of Wisconsin-Milwaukee, 3210 North Cramer Street, Milwaukee, Wisconsin 53211, USA.
Kabir
M Shahjahan
MS
Wang
Zhijian
Z
Rallapalli
Sundari K
SK
Ma
Jun
J
Cook
James M
JM
D000404:Ajmaline / Q000737:chemistry*; D000447:Aldehydes / Q000138:chemical synthesis* / Q000737:chemistry; D026121:Indole Alkaloids / Q000138:chemical synthesis* / Q000737:chemistry; D008968:Molecular Conformation; D013237:Stereoisomerism
C518016:16-epi-vellosimine; D000447:Aldehydes; D026121:Indole Alkaloids; C518014:polyneuridine; C518013:polyneuridine aldehyde; D000404:Ajmaline; C518015:macusine A
Eur J Obstet Gynecol Reprod Biol. 1994 Jul;56(1):63-6
7982519
Org Lett. 2000 Jul 27;2(15):2225-8
10930249
Acta Biol Med Ger. 1977;36(7-8):1193-6
612098
J Org Chem. 2003 Oct 3;68(20):7565-81
14510528
Planta Med. 1999 Dec;65(8):690-4
10630106
J Am Chem Soc. 2001 Apr 4;123(13):3183-5
11457049
J Org Chem. 1996 Nov 1;61(22):7873-7881
11667746
Planta Med. 1999 May;65(4):311-5
10364834
Org Lett. 2000 Jul 13;2(14):2057-9
10891229
J Org Chem. 2006 Jan 6;71(1):251-9
16388644
Am J Cardiol. 1996 Sep 12;78(5A):69-75
8820839
Org Lett. 2006 Mar 16;8(6):1017-20
16524257
Angew Chem Int Ed Engl. 2009;48(28):5211-3
19496101
Eur J Biochem. 2000 Mar;267(5):1397-406
10691977
J Org Chem. 2005 May 13;70(10):3963-79
15876085
J Org Chem. 2003 Jul 25;68(15):5852-9
12868917
Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1956;229(1):82-91
13348694
Planta Med. 1982 Aug;45(4):248-9
17396924
Przegl Lek. 1996;53(3):196-8
8754384
Org Lett. 2002 Dec 26;4(26):4681-4
12489960
J Org Chem. 2006 Nov 10;71(23):8884-90
17081019
Angew Chem Int Ed Engl. 1998 Mar 2;37(4):388-401
29711174
J Am Chem Soc. 2004 Feb 11;126(5):1358-9
14759191
Org Lett. 2008 Aug 7;10(15):3363-6
18611035
Org Lett. 2007 Jan 18;9(2):295-8
17217288
Chem Rev. 2000 Aug 9;100(8):3009-66
11749313